Covéa repricing suggests Europe heading the way of US for 1.1 cat renewal
Market resistance to firm order terms (FOTs) issued for Covéa will do little to encourage European cedants that they will be spared the hard market conditions that have turned discussions around the US cat renewal away from price to a scramble to secure capacity.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below